1.8 Obesity
| First line drugs | Second line drugs | Specialist drugs | Secondary care drugs |
Traffic light status (TLS) explained:
- Green: Routine prescribing within licensed indication
- Amber 1: specialist recommendation followed by GP initiation and continuation
- Amber 2: specialist or GP initiation in line with local guideline after 1st line failure followed by GP continuation
- Amber 3: specialist initiation and stabilisation followed by GP continuation
- Amber SCG: specialist initiation and stabilisation followed by GP continuation in line with an agreed shared care guideline
- Red: Hospital or specialist prescribing only
Useful resources
National Guidance
- Use as per NICE CG43 Obesity prevention (Dec 2006) Updated March 2015
- NICE guideline NG7: Maintaining a healthy weight and preventing excess weight gain among adults and children (March 2015)
Lipase Inhibitors
Orlistat (Amber 1)
- Capsules 120mg
Notes:
- Use as per NICE CG189 Obesity: identification, assessment and management (Nov 2014)
Return to Chapter: 1. Gastro-Intestinal System
Last updated by: Dupe Fagbenro on 05-02-2019 15:57
-
BNF
-
NICE
-
Summary of product characteristics
